Albumin for patients with acute large-vessel occlusive stroke undergoing endovascular therapy (ARISE): the protocol of a randomized double-blind trial
Yuanyuan Liu, Xunming Ji(Capital Medical University), Changming Wen(Nanyang Institute of Technology), Benxiao Wang, Jianqiao Li(Huaibei Mining (China)), Chuanhui Li(Capital Medical University), Wenhuo Chen, Yi Xu(Capital Medical University), Chen Zhou(Capital Medical University), Chuanjie Wu(Capital Medical University), Jing Xu(Wuhan Donghu University), Zhengfei Ma(Suzhou Municipal Hospital), Wenbo Li(The University of Texas MD Anderson Cancer Center), Xiaogang Li(Wuhan University), Xiaoman Zhang(Zhengzhou People's Hospital), Di Wu(Capital Medical University), Chaoqun Li(Zhejiang Cancer Hospital), Lei Yang, Xuehong Chu(Capital Medical University), Tingyu Yi(Fujian Medical University), Xiao Song Dong(Nanchang University), Chengbei Hou(Capital Medical University), Lei Shi(Ministry of Education), Yifeng Liu(Xuzhou Medical College), Jun Sun(University of Illinois Chicago)
Cited by 1
Related Papers
Stroke in China: advances and challenges in epidemiology, prevention, and management
|The Lancet Neurology|2019|1.6k
Transfer of mitochondria from astrocytes to neurons after stroke
|Nature|2016|1.4k
Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion
|New England Journal of Medicine|2022|707
Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion
|New England Journal of Medicine|2022|665